Edward M. Kaye M.D., CEO at Stoke Therapeutics, Inc. (STOK), sold 12,340 shares at $12.78 ($158K) on 2024-12-06, disclosed to the SEC on 2024-12-10.
Open-market sale of $158k STOK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.78 | 6,170 | $79K | 50.0% |
| 2 | $12.78 | 6,170 | $79K | 50.0% |
| Total | $12.78 avg | 12,340 | $158K | 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |